TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive ACS Board Approves Special Donors Concept, Oks New Program or Cause And Prevention Research February 23, 1979
TCL Archive Richard Klausner resigned from the Gates Foundation, saying move was unrelated to Congressional investigation of NCI contract to Harvard University during Klausner’s tenure as NCI director. September 16, 2005
